Ultragenyx Pharmaceutical Inc. buy Guggenheim
Start price
05.01.26
/
50%
€20.00
Target price
05.01.27
€44.47
Performance (%)
5.50%
Price
17.04.26
€20.66
Summary
This prediction is currently active. The BUY prediction by Guggenheim shows slight gains of 5.50%. This prediction currently runs until 05.01.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 4.873% | 4.873% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Guggenheim for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Guggenheim from $64.00 to $52.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Guggenheim for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€32.00
20.06.25
20.06.25
€55.59
20.06.26
20.06.26
-35.44%
17.04.26
17.04.26
